Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;51:574-580
Published online before print January 7, 2008, doi: 10.1161/HYPERTENSIONAHA.107.102764
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
51/2/574    most recent
HYPERTENSIONAHA.107.102764v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, P.
Right arrow Articles by Santos, R. A.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, P.
Right arrow Articles by Santos, R. A.S.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Genetically altered mice
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 2008;51:574.)
© 2008 American Heart Association, Inc.


Original Articles Part 2

Endothelial Dysfunction and Elevated Blood Pressure in Mas Gene-Deleted Mice

Ping Xu; Andrey C. Costa-Goncalves; Mihail Todiras; Luiza A. Rabelo; Walkyria O. Sampaio; Marina M. Moura; Sergio Sousa Santos; Friedrich C. Luft; Michael Bader; Volkmar Gross; Natalia Alenina; Robson A.S. Santos

From the Max-Delbrück-Center for Molecular Medicine (P.X., A.C.C-G., M.T., F.C.L., M.B., V.G., N.A.), Berlin, Germany; the Department of Physiology and Biophysics (A.C.C-G., L.A.R., W.O.S., M.M.M., S.S.S., R.A.S.S.), Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Setor de Fisiologia e Farmacologia (L.A.R.), Instituto de Ciências Biológicas e da Saúde (ICBS), Universidade Federal de Alagoas, Maceió, Brazil; and the Medical Faculty of the Charité (F.C.L.), Franz Volhard Clinic, HELIOS Klinikum, Berlin, Germany.

Correspondence to Natalia Alenina, Max-Delbrück-Center for Molecular Medicine, Robert-Rössle-Str 10, D-13125 Berlin-Buch, Germany. E-mail alenina{at}mdc-berlin.de

Mas codes for a G protein–coupled receptor that is implicated in angiotensin-(1-7) signaling. We studied the cardiovascular phenotype of Mas-deficient mice backcrossed onto the FVB/N genetic background using telemetry and found that they exhibit higher blood pressures compared with controls. These Mas–/– mice also had impaired endothelial function, decreased NO production, and lower endothelial NO synthase expression. Reduced nicotinamide-adenine dinucleotide phosphate oxidase catalytic subunit gp91phox protein content determined by Western blotting was higher in Mas–/– mice than in controls, whereas superoxide dismutase and catalase activities were reduced. The superoxide dismutase mimetic, Tempol, decreased blood pressure in Mas–/– mice but had a minimal effect in control mice. Our results show a major cardiovascular phenotype in Mas–/– mice. Mas-deletion results in increased blood pressure, endothelial dysfunction, and an imbalance between NO and reactive oxygen species. Our animals represent a promising model to study angiotensin-(1-7)–mediated cardiovascular effects and to evaluate Mas agonistic compounds as novel cardioprotective and antihypertensive agents based on their beneficial effects on endothelial function.


Key Words: Mas-deficient mice • endothelial function • Ang-(1-7) • reactive oxygen species • NO